[Etiological therapeutics in viral diseases].
D000212:Acyclovir / Q000627:therapeutic use; D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D017245:Foscarnet; D007065:Idoxuridine / Q000627:therapeutic use; D007111:Immunity, Cellular; D007113:Immunity, Innate; D007167:Immunotherapy / Q000662:veterinary; D007372:Interferons / Q000276:immunology / Q000627:therapeutic use; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D014740:Vidarabine / Q000627:therapeutic use; D014777:Virus Diseases / Q000188:drug therapy / Q000276:immunology / Q000628:therapy / Q000662:veterinary*; D014779:Virus Replication / Q000187:drug effects
D000914:Antibodies, Viral; D000998:Antiviral Agents; D017245:Foscarnet; D007372:Interferons; D000547:Amantadine; D014740:Vidarabine; D007065:Idoxuridine; D010746:Phosphonoacetic Acid; D000212:Acyclovir
Thérapeutique étiologique des maladies d'origine virale.